Sage Journals: Discover world-class research

Abstract

Background:

Numerous studies have shown that high C-reactive protein (CRP) levels predict cardiovascular disease and augur a poor prognosis in patients with acute coronary syndromes. Much in vitro and in vivo data support of a role for CRP in atherogenesis. There is an urgent need to develop inhibitors that specifically block the biological effects of CRP in vivo. The one-bead–one-compound (OBOC) combinatorial library method has been used to discover ligands against several biological targets. In this study, we use a novel fluorescence-based screening method to screen an OBOC combinatorial library for the discovery of peptides against human CRP.

Methods:

Human CRP was labeled with fluorescein isothiocyanate (FITC) and human serum albumin (HuSA) was labeled with phycoerythrin (PE) and used for screening. The OBOC library LWH-01 was synthesized on TentaGel resin beads using a standard solid-phase “split/mix” approach.

Results:

By subtraction screening, eight peptides that bind specifically to CRP and not to HuSA were identified. In human aortic endothelial cells (HAECs) incubated with CRP, inhibitors CRPi-2, CRPi-3, and CRPi-6 significantly inhibited CRP-induced superoxide, cytokine release, and nuclear factor-κB (NFκB) activity. Molecular docking studies demonstrate that CRPi-2 interacts with the two Ca²⁺ ions in the single subunit of CRP. The binding of CRPi-2 is reminiscent of choline binding.

Conclusions:

Future studies will examine the utility of this inhibitor in animal models and clinical trials.

Get full access to this article

View all access options for this article.

References

Libby

, Ridker

. Inflammation and atherosclerosis: Role of C-reactive protein in risk assessment. Am J Med, 2004; 116:9–16.

Bassuk

, Rifai

, Ridker

. High-sensitivity C-reactive protein: Clinical importance. Curr Probl Cardiol, 2004; 29:439–493.

Verma

, Devaraj

, Jialal

. C-reactive protein promotes atherothrombosis. Circulation, 2006; 113:2135–2150.

Devaraj

, Singh

, Jialal

. The evolving role of C-reactive protein in atherothrombosis. Clin Chem, 2009; 55:229–238.

Thompson

, Pepys

, Wood

. The physiological structure of human C-reactive protein and its complex with phosphocholine. Struct Folding Design, 1999; 7:69–177.

Hirschfield

, Pepys

. C-reactive protein and cardiovascular disease: New insights from an old molecule. Qjm-an Int J Med, 2003; 96:793–807.

Pepys

, Hirschfield

, Tennent

et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature, 2006; 440:1217–1221.

Lam

, Salmon

, Hersh

et al. A new type of synthetic peptide library for identifying ligand-binding activity. Nature, 1991; 354:82–84.

Al-Obeidi

, Lam

. Development of inhibitors for protein tyrosine kinases. Oncogene, 2000; 19:5690–5701.

10.

Lam

, Liu

, Miyamoto

et al. Applications of one-bead one-compound combinatorial libraries and chemical microarrays in signal transduction research. Accounts Chem Res, 2003; 36:370–377.

11.

Kim

, Park

, Shin

et al. Antibody-free peptide substrate screening of serine/threonine kinase (protein kinase A) with a biotinylated detection probe. Anal Biochem, 2011; 413:30–35.

12.

Meldal

, Svendsen

. Direct visualization of enzyme-inhibitors using a portion mixing inhibitor library containing a quenched fluorogenic peptide substrate. 1. Inhibitors for subtilisin Carlsberg. J Chem Soc Perkin Transact, 1995; 1:1591–1596.

13.

McBride

, Freeman

, Domingo

et al. Selection of chymotrypsin inhibitors from a conformationally-constrained combinatorial peptide library. J Mol Biol, 1996; 259:819–827.

14.

Kumaresan

, Natarajan

, Song

et al. Development of tissue plasminogen activator specific "on demand cleavable" (ODC) linkers for radioimmunotherapy by screening one-bead-one-compound combinatorial peptide libraries. Bioconj Chem, 2007; 18:175–182.

15.

Roof

, Sobczyk-Kojiro

, Turbiak

et al. Novel peptide ligands of RGS4 from a focused one-bead, one-compound library. Chem Biol Drug Design, 2008; 72:111–119.

16.

Gruber

, Muttenthaler

, Freissmuth

. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr Pharmaceut Design, 2010; 16:3071–3088.

17.

Redman

, Ladame

, Reszka

et al. Discovery of G-quadruplex stabilizing ligands through direct ELISA of a one-bead-one-compound library. Org Biomol Chem, 2006; 4:4364–4369.

18.

Murray

, Sadowsky

, Scalf

et al. Exploration of structure—activity relationships among foldamer ligands for a specific protein binding site via parallel and split-and-mix library synthesis. J Comb Chem, 2008; 10:204–215.

19.

Peng

, Liu

, Marik

et al. Combinatorial chemistry identifies high-affinity peptidomimetics against alpha(4)beta(1) integrin for in vivo tumor imaging. Nat Chem Biol, 2006; 2:381–389.

20.

Aina

, Liu

, Sutcliffe

et al. From combinatorial chemistry to cancer-targeting peptides. Mol Pharmaceut, 2007; 4:631–651

21.

Kumaresan

, Ahir

, Liu

et al. Identification of cancer specific high affinity targeting ligands by screening One-bead-one-compound and small molecule. Mol Cancer Therapeut, 2007; 6:3408s–3408s.

22.

Xiao

, Wang

, Lau

et al. The use of one-bead one-compound combinatorial library technology to discover high-affinity alpha v beta 3 integrin and cancer targeting arginine-glycine-aspartic acid ligands with a built-in handle. Mol Cancer Therapeut, 2010; 9:2714–2723.

23.

Kumaresan

, Wang

, Saunders

et al. Rapid discovery of death ligands with one-bead-two-compound combinatorial library methods. ACS Comb Sci, 2011; 13:259–264.

24.

Duclos

, Zlock

, Marnell

. Definition of a C-reactive protein-binding determinant on histones. J Biol Chem, 1991; 266:2167–2171.

25.

Dasu

, Devaraj

, Du Clos

et al. The biological effects of CRP are not attributable to endotoxin contamination: Evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res, 2007; 48:509–512.

26.

Lebl

, Krchnak

, Sepetov

et al. Synthetic combinatorial libraries—a new tool for drug design—methods for identifying the composition of compounds from peptide and/or nonpeptide libraries. J Prot Chem, 1994; 13:484–486.

27.

Lam

, Lebl

, Krchnak

. The ''one-bead-one-compound'' combinatorial library method. Chem Rev, 1997; 97:411–448.

28.

Lam

, Lehman

, Song

et al. Synthesis and screening of “one-bead one-compound” combinatorial peptide libraries. Comb Chem Pt B, 2003; 369:298–322.

29.

Kumaresan

, Lam

. Screening chemical microarrays: methods and applications. Mol Biosyst, 2006; 2:259–270.

30.

Liu

, Lam

. Automatic Edman microsequencing of peptides containing multiple unnatural amino acids. Anal Biochem, 2001; 295:9–16.

31.

Devaraj

, Dasu

, Singh

et al. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis, 2009; 203:67–74.

32.

Singh

, Devaraj

, Dasu

et al. C-reactive protein decreases interleukin-10 secretion in activated human monocyte-derived macrophages via inhibition of cyclic AMP production. Arterioscler Thromb Vasc Biol, 2006; 26:2469–2475.

33.

Singh

, Dasu

, Yancey

et al. Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J of Lipid Res, 2008; 49:1015–1023.

34.

Devaraj

, Kumaresan

, Jialal

. Effect of C-reactive protein on chemokine expression in human aortic endothelial cells. J Mol Cell Cardiol, 2004; 36:405–410.

35.

Cornell

, Cieplak

, Bayly

et al. A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc, 1996; 118:2309–2309.

36.

Jakalian

, Bush

, Jack

et al. Fast, efficient generation of high-quality atomic Charges. AM1-BCC model: I. Method. J Comput Chem, 2000; 21:132–146.

37.

Morris

, Huey

, Lindstrom

et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem, 2009; 30:2785–2791.

38.

Legge

, Morris

, Sanner

et al. Model of the alpha L beta 2 integrin I-domain/ICAM-1 DI interface suggests that subtle changes in loop orientation determine ligand specificity. Proteins Struct Funct Genet, 2002; 48:151–160

39.

Wang

, Wang

, Kollman

et al. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model, 2006; 25:247–260.

40.

Bisoendial

, Birjmohun

, Keller

et al. Letter to the editor. Circ Res, 2005; 97:E115–E116.

41.

Bisoendial

, Kastelein

JJP

, Peters

SLM

et al. Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. J Lipid Res, 2007; 48:952–960.

42.

Ridker

, Cannon

, Morrow

et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med, 2005; 352:20–28.

43.

Ridker

, Danielson

, Fonseca

FAH

et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008; 359:2195–2207.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.02 MB

Synthesis and Characterization of a Novel Inhibitor of C-Reactive Protein–Mediated Proinflammatory Effects

Abstract

Background:

Methods:

Results:

Conclusions:

Get full access to this article

References

Supplementary Material